1.180

-0.010 (-0.8%)
Language:

(吉隆坡24日讯)市场对美国企业财报依然乐观,隔夜美国股市全面上涨,提振亚太股市今日全面攀升,马股获得医疗股和产业股推动一度涨破1570点,不过休市退守至1568.59点。开盘时,富时综指先升至1565.49点,开盘不久更是涨至1571.04点,过后涨幅收窄,休市收报1568.59点,半日升6.95点。综指成分股中,由21只上升,其中包括国油贸易(PETDAG,5681,主板消费产品服务组)涨20仙至21令吉80仙,是第七大上升股;吉隆坡甲洞(KLK,2445,主板种植组)和PPB集团(PP...
Sinchew24 Apr, 2024 13:18pm - 1 day

KUALA LUMPUR: RHB Research forecasts a stronger performance in the private healthcare sector this year, propelled by factors such as organic expansion efforts and boosted tourism from China and India with visa-free entry.The firm highlights that an increasing prevalence ...
NST24 Apr, 2024 08:21am - 1 day

FORMER Permodalan Nasional Bhd (PNB) president and CEO Datuk Abdul Rahman Ahmad is expected to make a comeback at the country’s largest unit trust fund manager after being coaxed to return by chairman Raja Tan Sri Arshad Raja Tun Uda. It is understood that while Abdul Rahman was hesitan...
TheEdge08 Apr, 2024 15:30pm - 2 weeks

KPJ Healthcare Bhd Target price: RM1.86 OVERWEIGHT
TheEdge18 Mar, 2024 14:30pm - 1 month

(吉隆坡15日讯)马化工联药(DPHARMA,7148,主要板医疗保健)宣布,与英国可负担药业中心(CADT)和荷兰PAMOJA制药公司签署了谅解备忘录,以合作在我国进行药物再利用研究。马化工联药董事经理里奥纳德阿礼夫在文告中指出,此项合作主要是为现有药物研发新用法。“作为大马领先的保健品牌,我相信...
Chinapress15 Mar, 2024 19:33pm - 1 month

(吉隆坡14日讯)联合药业(DPHARMA,7148,主板保健股)与英国可负担药业中心(CADT)荷兰PAMOJA药业签署了解备忘录,合作在我国进行药物再利用研究。联合药业董事经理莱纳德在文告中表示,此项合作主要是为现有药物研发新用法。“作为大马领先的保健品牌,我相信这项研究能让患者在短时间内拥有过...
Nanyang14 Mar, 2024 18:15pm - 1 month

券商 :兴业投银研究投资建议 :买进目标价 :1.41令吉闭市价 :1.18令吉(截至3月8日)每股收益 :9仙(2024财年预估)本益比 :13.27倍(2024财年预估)股息收益率 :2.0%(2024财年预估)ESG评分 :3分(总分为4分)由于赚幅高于同行、政府对医疗保健领域的预算分配提高,...
Chinapress08 Mar, 2024 20:33pm - 1 month

KUALA LUMPUR: RHB research has recommended a buy call on Duopharma Biotech Bhd because it sees good prospects for the company in the medium to long term, supported by the rise in non-communicable diseases (NCD) and the growing number of ...
NST08 Mar, 2024 12:00pm - 1 month

DUOPHARMA Biotech Bhd is set to report weaker revenue and earnings for the financial year ended Dec 31, 2023 (FY2023), its first annual profit decline in four years. This comes amid a double whammy of higher operational costs and a dip in demand, which group managing director and executive direct...
TheEdge27 Feb, 2024 16:00pm - 1 month

Duopharma Biotech Bhd aims to deliver a satisfactory performance in 2024, underpinned by the positive advancements and anticipated growth in the economy and industry.
TheStar23 Feb, 2024 00:00am - 2 months

(吉隆坡22日讯)由于营运成本上涨、消费者保健领域需求下滑,马化工联药(DPHARMA,7148,主要板医疗保健)截至12月底2023财年末季,净利按年挫跌50.5%至850万令吉,写下7年来最差季度表现。该公司向马证交所报备,末季营业额按年上涨10.2%至1亿6750万令吉。全年净利按年减少24....
Chinapress22 Feb, 2024 20:33pm - 2 months

Pharmaceutical company Duopharma Biotech Bhd said on Thursday its quarterly net profit more than halved to its lowest in seven years, hurt by lower margins and higher finance costs.
TheEdge22 Feb, 2024 19:44pm - 2 months

KUALA LUMPUR: Duopharma Biotech Bhd aims to deliver a satisfactory performance in 2024, underpinned by the positive advancements and anticipated growth in the economy and industry.
TheStar22 Feb, 2024 18:50pm - 2 months

Duopharma Biotech Bhd is likely to see a recovery in its consumer healthcare (CHC) segment, while sales to the government sector is also expected to increase in 2024.
TheStar26 Jan, 2024 00:00am - 3 months

KUALA LUMPUR (Jan 19): RHB Investment Bank Bhd (RHB IB) has maintained its “overweight” rating on the healthcare sector, amid expectations the private healthcare sector’s earnings growth will persist into 2024.
TheEdge19 Jan, 2024 11:51am - 3 months

KUALA LUMPUR: RHB research expects the private healthcare sector's earnings growth to persist into 2024.The investment bank said this is underpinned by relatively inelastic demand, rising health awareness among consumers, and a rapidly ageing society anchoring generic drugmakers' mid- ...
NST19 Jan, 2024 09:10am - 3 months

This article first appeared in The Edge Malaysia Weekly on January 8, 2024 - January 14, 2024 AMONG The Edge’s stock picks in 2023, Bermaz Auto Bhd, Tenaga Nasional Bhd (TNB) and Inari Amertron Bhd were the top performers, with total returns of 24%, 12.9% and 18.7% ...
TheEdge18 Jan, 2024 14:35pm - 3 months

Strong buying interest needed to end FBM KLCI profit-taking spreeGovindan Kaladher The local stock market ended the final trading week of 2023 on a whimper, with the lack of local market leads and most investors away for the Christmas and New ...
NST02 Jan, 2024 08:47am - 3 months

KUALA LUMPUR: Trend semasa peningkatan kes COVID-19 sejak beberapa minggu ini telah mendorong minat belian pelabur terhadap kaunter sarung tangan getah dan penjagaan kesihatan. Ini dapat disaksikan dengan kaunter Careplus Group Bhd dan Top Glove Corp Bhd menjadi antara kaunter ...
BeritaHarian19 Dec, 2023 14:20pm - 4 months

(吉隆坡18日讯)尽管新冠疫情升温,但投资者情绪未受太大影响,富时综合指数收市报1465.28点,全天升2.83点或0....
Orientaldaily18 Dec, 2023 18:17pm - 4 months